Invasive Bladder Carcinoma — Trials

Invasive Bladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

179 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 95
Recruiting: 59
Ph III recruiting: 12
Growth YoY: +28.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 58.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05316155	Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer	active not recruiting	Phase 1 / Phase 2	235	Janssen Research & Development, LLCINDUSTRY	8	Sep 25, 2026	clinicaltrials
NCT04506554	A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer	active not recruiting	Phase 2	81	Fox Chase Cancer CenterOTHER	1	Sep 21, 2026	clinicaltrials